Norinchukin Bank The Acquires 2,211 Shares of Aflac Incorporated (NYSE:AFL)

Norinchukin Bank The boosted its stake in shares of Aflac Incorporated (NYSE:AFL) by 10.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,458 shares of the financial services provider’s stock after purchasing an additional 2,211 shares during the quarter. Norinchukin Bank The’s holdings in Aflac were worth $2,426,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Whipplewood Advisors LLC bought a new stake in shares of Aflac during the 4th quarter worth about $26,000. BankPlus Trust Department acquired a new stake in Aflac during the fourth quarter worth approximately $34,000. Curio Wealth LLC bought a new stake in shares of Aflac during the fourth quarter worth approximately $36,000. OFI Invest Asset Management acquired a new position in shares of Aflac in the fourth quarter valued at approximately $38,000. Finally, Rialto Wealth Management LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $41,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.

Aflac Price Performance

Aflac stock opened at $107.35 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a 52 week low of $80.59 and a 52 week high of $115.50. The stock has a market capitalization of $58.59 billion, a P/E ratio of 11.18, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The stock has a fifty day moving average of $106.72 and a 200-day moving average of $107.28.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AFL has been the topic of a number of research reports. BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective on the stock. Morgan Stanley decreased their price target on shares of Aflac from $105.00 to $100.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 10th. Keefe, Bruyette & Woods dropped their price objective on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. JPMorgan Chase & Co. increased their target price on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Finally, Piper Sandler lifted their price target on shares of Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Aflac has a consensus rating of “Hold” and a consensus target price of $103.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.